Half-year report · Q2
4578.TEDINET S100WFZ0
Period2025-01-01 → 2025-06-30
Filed2025-07-31
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.18T | 2025-01-01 → 2025-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥2.33T | 2024-01-01 → 2024-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.11T | 2024-01-01 → 2024-06-30 | Cons. | Revenue IFRS |
| Operating income | ¥242.1bn | 2025-01-01 → 2025-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥126.3bn | 2024-01-01 → 2024-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥226.3bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥335.9bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥142.2bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥173.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥343.1bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥107.8bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥175.9bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥110.6bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥3.79T | at 2025-06-30 | Cons. | Assets IFRS |
| Total assets | ¥3.74T | at 2024-12-31 | Cons. | Assets IFRS |
| Total assets | ¥3.66T | at 2024-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥1.00T | at 2025-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥961.1bn | at 2024-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥2.79T | at 2025-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.78T | at 2024-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.67T | at 2024-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.44T | at 2023-12-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥2.72T | at 2025-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.73T | at 2024-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.62T | at 2024-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥411.1bn | at 2025-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥426.2bn | at 2024-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥485.9bn | at 2024-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥513.3bn | at 2023-12-31v | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥212.7bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥354.6bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥133.0bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥130.9bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥265.8bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥159.2bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥85.4bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥189.4bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥26.2bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥326.12 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥633.76 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥198.61 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share IFRS |
| Equity ratio | 71.8% | at 2025-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 73.1% | at 2024-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.6% | at 2024-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-01-01 → 2025-06-30 | ¥56.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-01-01 → 2025-06-30 | ¥55.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-06-30 | ¥5.0bn |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥27.8bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥15.8bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥15.8bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥9m |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥12.9bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥276.1bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥276.0bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥19m |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥36.7bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥833.8bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥833.8bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥215.4bn |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥1.18T |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥1.18T |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1.7bn |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥269.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-06-30 | ¥56.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-06-30 | ¥54.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-06-30 | ¥4.8bn |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥1.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥1.8bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥24.2bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥15.7bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥15.7bn |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥3m |
| jpcrp040300-q2r_E21183-000Consumer Productsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥12.3bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥271.8bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥271.8bn |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥15m |
| jpcrp040300-q2r_E21183-000Nutraceuticalsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥37.3bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥766.7bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥766.7bn |
| jpcrp040300-q2r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥96.0bn |
| —segment total | revenue | 2024-01-01 → 2024-06-30 | ¥1.11T |
| —segment total | revenue external | 2024-01-01 → 2024-06-30 | ¥1.11T |
| —segment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.8bn |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥150.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 782
| Item | Context | Value | Unit |
|---|---|---|---|
| Other current assets ca IFRS | CurrentQuarterInstant | 98734000000 | JPY |
| Current assets other than assets held for sale ca IFRS | Prior1YearInstant | 1366972000000 | JPY |
| Current assets other than assets held for sale ca IFRS | CurrentQuarterInstant | 1390322000000 | JPY |
| Assets held for sale IFRS | Prior1YearInstant | － | JPY |
| Assets held for sale IFRS | CurrentQuarterInstant | 957000000 | JPY |
| Current assets IFRS | Prior1YearInstant | 1366972000000 | JPY |
| Current assets IFRS | CurrentQuarterInstant | 1391279000000 | JPY |
| Property plant and equipment IFRS | Prior1YearInstant | 628544000000 | JPY |
| Property plant and equipment IFRS | CurrentQuarterInstant | 641068000000 | JPY |
| Goodwill IFRS | Prior1YearInstant | 449464000000 | JPY |
| Goodwill IFRS | CurrentQuarterInstant | 482278000000 | JPY |
| Intangible assets IFRS | Prior1YearInstant | 544247000000 | JPY |
| Intangible assets IFRS | CurrentQuarterInstant | 540528000000 | JPY |
| Investments accounted for using equity method IFRS | Prior1YearInstant | 314780000000 | JPY |
| Investments accounted for using equity method IFRS | CurrentQuarterInstant | 319297000000 | JPY |
| Other financial assets nca IFRS | Prior1YearInstant | 206272000000 | JPY |
| Other financial assets nca IFRS | CurrentQuarterInstant | 190712000000 | JPY |
| Deferred tax assets IFRS | Prior1YearInstant | 205700000000 | JPY |
| Deferred tax assets IFRS | CurrentQuarterInstant | 200001000000 | JPY |
| Other non current assets nca IFRS | Prior1YearInstant | 23267000000 | JPY |
| Other non current assets nca IFRS | CurrentQuarterInstant | 24131000000 | JPY |
| Non current assets IFRS | Prior1YearInstant | 2372278000000 | JPY |
| Non current assets IFRS | CurrentQuarterInstant | 2398018000000 | JPY |
| Assets IFRS | Prior1YearInstant | 3739251000000 | JPY |
| Assets IFRS | CurrentQuarterInstant | 3789298000000 | JPY |
| Trade and other payables2 cl IFRS | Prior1YearInstant | 219996000000 | JPY |
| Trade and other payables2 cl IFRS | CurrentQuarterInstant | 209845000000 | JPY |
| Bonds and borrowings cl IFRS | Prior1YearInstant | 7350000000 | JPY |
| Bonds and borrowings cl IFRS | CurrentQuarterInstant | 37707000000 | JPY |
| Lease liabilities cl IFRS | Prior1YearInstant | 21146000000 | JPY |
| Lease liabilities cl IFRS | CurrentQuarterInstant | 20043000000 | JPY |
| Other financial liabilities cl IFRS | Prior1YearInstant | 4387000000 | JPY |
| Other financial liabilities cl IFRS | CurrentQuarterInstant | 2162000000 | JPY |
| Income taxes payable cl IFRS | Prior1YearInstant | 29250000000 | JPY |
| Income taxes payable cl IFRS | CurrentQuarterInstant | 49422000000 | JPY |
| Provisions cl IFRS | Prior1YearInstant | 1242000000 | JPY |
| Provisions cl IFRS | CurrentQuarterInstant | 656000000 | JPY |
| Contract liabilities cl IFRS | Prior1YearInstant | 13952000000 | JPY |
| Contract liabilities cl IFRS | CurrentQuarterInstant | 12278000000 | JPY |
| Other current liabilities cl IFRS | Prior1YearInstant | 335338000000 | JPY |
| Other current liabilities cl IFRS | CurrentQuarterInstant | 343721000000 | JPY |
| Total current liabilities IFRS | Prior1YearInstant | 632664000000 | JPY |
| Total current liabilities IFRS | CurrentQuarterInstant | 675838000000 | JPY |
| Bonds and borrowings ncl IFRS | Prior1YearInstant | 87275000000 | JPY |
| Bonds and borrowings ncl IFRS | CurrentQuarterInstant | 86547000000 | JPY |
| Lease liabilities ncl IFRS | Prior1YearInstant | 73612000000 | JPY |
| Lease liabilities ncl IFRS | CurrentQuarterInstant | 67211000000 | JPY |
| Other financial liabilities ncl IFRS | Prior1YearInstant | 53127000000 | JPY |
| Other financial liabilities ncl IFRS | CurrentQuarterInstant | 60748000000 | JPY |
| Income taxes payable ncl IFRS | Prior1YearInstant | 1584000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |